摘要
目的评价胺碘酮治疗急性冠状动脉综合征(acute coronary syndrome,ACS)伴急性心力衰竭(acute heart failure,AHF)的室上性心动过速(supraventricular tachycardia,SVT)的临床疗效。方法回顾性分析接受胺碘酮治疗的11例伴SVT的ACS合并AHF患者的临床资料。结果在常规治疗无效时,对11例患者进行静脉应用胺碘酮治疗,其中9例(81.8%)迅速好转并顺利出院,1例死于心源性休克,另有1例需电击复律。结论对于伴SVT的AHF患者,要考虑ACS的可能;使用胺碘酮治疗安全有效。
Objective To evaluate the clinical efficacy of amiodarone in the treatment of patients with supraventricular tachycardia(SVT)of acute coronary syndrome(ACS)and acute heart failure(AHF).Methods Retrospectively analyze the clinical data from 11 patients who were diagnosed with ACS and AHF with SVT.Results When conventional treatment proved invalid,intravenous amiodarone therapy was carried out.Among 11 patients,9(81.8%)improved rapidly and cured at last and one died of cardiac shock as well as electric cardioversion was applied in another case.Conclusion The possibility of ACS must be considered in patients with SVT and AHF.Amiodarone can be used effectively and safely to control SVT in patients with ACS and AHF.
出处
《江苏实用心电学杂志》
2013年第3期681-683,共3页
Journal of Practical Electrocardiology JS
